Anaplastic large-cell lymphoma: Clinical and prognostic evaluation of 90 adult patients

Journal of Clinical Oncology

Volumn 14, Issue 3, 1996, Pages 955-962

  Zinzani, P L ^a   Bendandi, M ^a   Martelli, M ^a   Falini, B ^a   Sabattini, E ^a   Amadori, S ^a   Gherlinzoni, F ^a   Martelli, M F ^a   Mandelli, F ^a   Tura, S ^a   Pileri, S A ^a  

^a Institute of Hematology 'L e A Serágnoli'   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; FLUOROURACIL; FOLINIC ACID; METHOTREXATE; PREDNISONE; VINCRISTINE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; B CELL LYMPHOMA; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; HISTOLOGY; HUMAN; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; T CELL LYMPHOMA;

EID: 9044244142     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.3.955     Document Type: Article

References (57)

1. Schwab U, Stein H, Gerdes J, et al: Production of a monoclonal antibody specific for Hodgkin and Sternberg-Reed cells of Hodgkin's disease and a subset of normal lymphoid cells. Nature 299:65-67, 1982
2. Schwarting R, Gerdes J, Durkop H, et al: Ber-H2: A new anti Ki-1 (CD30) monoclonal antibody directed at a formol-resistant epitope. Blood 74:1678-1689, 1989
3. Stein H, Mason DY, Gerdes J, et al: The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: Evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cell. Blood 66:848-858, 1985
4. Stansfeld AG, Diebold J, Kapanci Y, et al: Updated Kiel classification for lymphomas. Lancet 1:292-293, 1988
5. Harris NL, Jaffe ES, Stein H, et al: A proposal for an international consensus on the classification of lymphoid neoplasms. Blood 84:1361-1392, 1994
6. Chang KL, Arber DA, Weiss LM: CD30: A review. Appl Immunohistochem 1:244-255, 1993
7. Falini B, Pileri S, Pizzolo G, et al: CD 30 (Ki-1) molecule: A new cytokine receptor of the TNF receptor superfamily as a target for diagnosis and immunotherapy. Blood 85:1-14, 1995
8. Stein H, Herbst H, Anagnostopoulos I, et al: The nature of Hodgkin and Reed-Sternberg cells, their association with EBV, and their relationship to anaplastic large cell lymphoma. Ann Oncol 2:33-38, 1991
9. Stein H, Gerdes J, Tippelmann G, et al: Ki-1 lymphoma: Experimental and clinical findings. Third International Conference on Malignant Lymphoma. Lugano, Switzerland, 21, 1987
10. Agnarsson BA, Kadin EK: Ki-1 positive large cell lymphoma. Am J Surg Pathol 12:264-274, 1988
11. +) anaplastic large cell lymphomas. Am J Pathol 135:359-367, 1989
12. Pileri S, Mazza P, Zinzani PL, et al: Ki-1 lymphoma and Hodgkin's disease. Haematologica 74:333-335, 1989
13. Chott A, Kaserer K, Augustin I, et al: Ki-1 positive large cell lymphoma. A clinicopathologic study of 41 cases. Am J Surg Pathol 14:439-448, 1990
14. Greer JP, Kinney MC, Collins RD, et al: Clinical features of 31 patients with Ki-1 anaplastic large cell lymphoma. J Clin Oncol 9:539-547, 1991
15. Nakamura S, Takagu N, Kojima M, et al: Clinicopathologic study of large cell anaplastic lymphoma (Ki-1 positive large cell lymphoma) among the Japanese. Cancer 68:118-129, 1991
16. Dumont J, Charpy-Vilidire P, Raphael M, et al: Lymphomes à grandes cellules: Influence des groupes histologiques sur le prognostic. Etude de 210 cas soumis aux memes protocoles therapeutiques. Arch Anat Cytol Pathol 40:110-114, 1992
17. Stein H: Ki-1 anaplastic large cell lymphoma: Is it a discrete entity? Leuk Lymphoma 10:81-84, 1993
18. + large-cell non-Hodgkin's lymphoma. J Clin Oncol 12:895-898, 1994
19. + anaplastic large cell lymphoma - A distinct clinicopathologic entity. Ann Oncol 5:S25, 1994
20. Pileri S, Bocchia M, Baroni CD, et al: Anaplastic large cell lymphoma (CD30+/Ki-1+): Results of a prospective clinico-pathological study of 69 cases. Br J Haematol 86:513-523, 1994
21. Longo G, Federico M, Pieresca C, et al: Ki-1 anaplastic large cell lymphoma. Analysis of 35 cases followed at GISL centers. Eur J Cancer 31A:1763-1767, 1995
22. Pileri SA, Piccaluga A, Poggi S, et al: Anaplastic large cell lymphoma: Update of findings. Leuk Lymphoma 18:17-25, 1995
23. Pileri SA: Controversies on Hodgkin's disease and anaplastic large cell lymphoma. Haematologica 79:299-310, 1994
24. +) in childhood. Med Pediatr Oncol 21:402-410, 1993
25. Reiter A, Schrappe M, Tiemann M, et al: Successful treatment strategy for Ki-1 anaplastic large-cell lymphoma of childhood: A prospective analysis of 62 patients enrolled in three consecutive Berlin-Frankfurt-Munster group studies. J Clin Oncol 12:899-908, 1994
26. Murphy SB: Pediatric lymphomas: Recent advances and commentary on Ki-1 positive anaplastic large cell lymphomas of childhood. Ann Oncol 5:31-33, 1994 (suppl 1)
27. Chan JKC, Hui PK, Leungs TW, et al: Anaplastic large cell Ki-1 lymphoma: Delineation of 2 morphological types. Histopathology 15:11-34, 1989
28. Chan JKC, Buchanam R, Fletcher CDM: Sarcomatoid variant of anaplastic large-cell Ki-1 lymphoma. Am J Surg Pathol 14:983-988, 1990
29. Kinney MC, Glick AD, Stein H, Collins RD: Comparison of anaplastic large cell Ki-1 lymphomas and microvillous lymphomas in their immunologic and ultrastructural features. Am J Surg Pathol 14:1047-1060, 1990
30. + with a high content of reactive histiocytes). Histopathology 16:383-391, 1990
31. + lymphoma. Am J Surg Pathol 17:859-868, 1993
32. Pileri S, Sabattini E, Poggi S, et al: Lymphohistiocytic T-cell lymphoma. Histopathology 25:191-193, 1994
33. O'Connor NTJ, Stein H, Gatter KC, et al: Genotypic analysis of Ki-1 positive large cell lymphomas. Histopathology 11:733-740, 1987
34. Herbst H, Tippelmann G, Anagnostopoulos I, et al: Immunoglobulin and T-cell receptor gene rearrangements in Hodgkin's disease and Ki-1 positive anaplastic large cell lymphoma: dissociation between phenotype and genotype. Leuk Res 13:103-116, 1989
35. Mason DY, Bastard C, Rimokh R, et al: CD30-positive large cell lymphomas ("Ki-1 lymphoma") are associated with a chromosomal translocation involving 5q35. Br J Haematol 74:161-168, 1990
36. Orscheschek K, Merz H, Hell J, et al: Large-cell anaplastic lymphoma-specific translocation (t[2;5] [p23;q35]) in Hodgkin's disease: Indication of a common pathogenesis? Lancet 1:87-90, 1995
37. Leoncini L, Del Vecchio MT, Kraft R, et al: Hodgkin's disease and CD30 positive anaplastic large cell lymphomas: A continuous spectrum of malignant disorders. Am J Pathol 137:1047-1057, 1990
38. Frizzera G: The distinction of Hodgkin's disease from anaplastic large cell lymphoma. Semin Diagn Pathol 9:291-296, 1992
39. Carbone PP, Kaplan HS, Musshoff K, et al: Report of the Committee on Hodgkin's Disease Staging Classifications. Cancer Res 31:1860-1861, 1971
40. Oken M, Creech R, Tormey D: Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649-655, 1982
41. Falini B, Pileri S, Martelli MF: Histological and immunohistological analysis of human lymphomas. Crit Rev Oncol Hematol 9:351-419, 1989
42. Cordell JL, Falini B, Erber WN, et al: Immunoenzymatic labelling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 32:219-229, 1984
43. Cattoretti G, Pileri S, Parravicini C, et al: Antigen unmasking on formalin-fixed, paraffin-embedded tissue sections. J Pathol 171:83-89, 1993
44. Mason DY, Cordell JL, Brown M, et al: CD79: A novel marker for B cell neoplasms in routinely processed tissue samples. Blood 86:1453-1459, 1995
45. Al Saati T, Tkaczuk J, Krissansen G, et al: A novel antigen detected by CBF.78 antibody futher distinguishes anaplastic large cell lymphoma from Hodgkin's disease. Blood 86:2741-2746, 1995
46. Guglielmi C, Amadori S, Anselmo AP, et al: Sequential chemotherapy of high-grade non-Hodgkin's lymphoma with 5-fluorouracil, methotrexate, cytosine-arabinoside, cyclophosphamide, doxorubicin vincristine and prednisone (F-MACHOP). Cancer Invest 5:159-169, 1987
47. Klimo P, Connors JM: MACOP-B chemotherapy for thr treatment of the diffuse large-cell lymphoma. Ann Intern Med 102:190-195, 1985
48. Hryniuk WM, Bush H: The importance of dose intensity in chemotherapy of metastatic breast cancer. J Clin Oncol 2:1281-1288, 1984
49. Kaplan EL, Meyer P: Non parametric estimation from incomplete observations. JAMA 53:457-481, 1958
50. Cox DR: Analysis of Binary Data. London, United Kingdom, Methuen, 1970
51. Cox DR: Regression models and life tables (with discussion). J R Stat Soc B 34:187-220, 1972
52. The International Non-Hodgkin's Lymphoma Prognostic Factors Project: A predictive model for aggressive non-Hodgkin's lymphoma. The International non-Hodgkin's lymphoma Prognostic Factors Project. N Engl J Med 329:987-994, 1993
53. Mazza P, Zinzani PL, Martelli M, et al: MACOP-B vs F-MACHOP regimen in the treatment of high-grade non-Hodgkin's lymphomas. Leuk Lymphoma 16:457-463, 1995
54. MacLennan KA, Bennett MH, Vaughan Hudson B, et al: Relationship of histopathologic features to survival and relapse in nodular sclerosing Hodgkin's disease. Cancer 64:1686-1693, 1989
55. Strickler JG, Michie SA, Warnke RA, et al: The "syncytial" variant of nodular sclerosing Hodgkin's disease. Am J Surg Pathol 10:470-477, 1986
56. Ageitos AG, Lobo F, Obeso G, et al: Ki-1 positive anaplastic large-cell lymphoma (Ki-1+ ALCL) and Hodgkin's disease (HD). Two related diseases? A clinico-pathological study. VII Meeting of the European association for Haematopathology, Toledo, Spain, October 3-6, 1994
57. Georgii A, Hubner K, Fischer R, Diehl V: Histologic typing of 3.000 Hodgkin's lymphomas: report from the german therapy trial. VII Meeting of the European Association for Haematopathology, Toledo, Spain, October 3-6, 1994